Vastarel MR 35mg Tablets – Trimetazidine Angina Treatment
Vastarel MR 35mg Tablets contain Trimetazidine in a modified-release formulation — a metabolic anti-ischaemic agent for long-term management of stable angina. Unlike other anti-anginals, Trimetazidine works at the cellular level by improving myocardial energy efficiency during ischaemia without affecting heart rate or blood pressure. May also help manage vertigo and tinnitus of vascular origin. Use under physician supervision.
Pay in 3 Installments of
Rs.
314
Vastarel Mr 35mg Tablets – Trimetazidine Angina Treatment
Description
Vastarel MR 35mg Tablets – Trimetazidine for Stable Angina
Vastarel MR 35mg Tablets contain Trimetazidine in a modified-release formulation. Trimetazidine is an anti-ischaemic agent with a unique mechanism — rather than affecting heart rate or blood pressure, it acts at the cellular level by inhibiting mitochondrial long-chain 3-ketoacyl CoA thiolase (3-KAT), thereby favouring glucose oxidation over fatty acid oxidation. This metabolic shift improves myocardial energy efficiency during ischaemia, reducing cellular acidosis and preserving ATP production. The clinical result is relief of anginal symptoms and improved exercise tolerance in patients with stable angina.
In addition to angina, Vastarel MR may be prescribed for vertigo and tinnitus of vascular origin, where it supports cochlear and vestibular blood flow. The MR formulation ensures twice-daily dosing with sustained plasma levels. Vastarel MR should be used as part of a comprehensive cardiac management plan alongside other anti-anginal agents as prescribed. It is contraindicated in severe renal impairment and in Parkinson's disease or related movement disorders.
Key Benefits
- Metabolic anti-ischaemic action: improves myocardial energy use without haemodynamic effects
- Reduces anginal episodes and improves exercise tolerance in stable angina
- May alleviate vertigo and tinnitus of vascular origin
- Modified-release formulation for convenient twice-daily dosing
Related Products
Browse our general medicines collection or explore essential health products for cardiac and vascular therapy support.
How to Order at Derma.pk
Nationwide delivery across Pakistan. Email prescription to sales@derma.pk or WhatsApp +92-320-5999650. Prescription required.
Usage & Benefits
- Trimetazidine: unique metabolic anti-ischaemic mechanism (3-KAT inhibition)
- Reduces anginal episodes and improves exercise tolerance in stable angina
- Does not affect heart rate or blood pressure — complements other anti-anginal agents
- Modified-release (MR) formulation for twice-daily dosing with sustained effect
- May alleviate vertigo and tinnitus of vascular origin
How To Use
FAQs
What is Vastarel MR used for?
It is used for the long-term treatment of stable angina pectoris (chest pain on exertion) and may help manage vertigo and tinnitus of vascular origin.
How does Trimetazidine differ from other anti-anginal drugs?
Unlike nitrates, beta-blockers, or calcium channel blockers, Trimetazidine works at the cellular level by improving how the heart uses energy during ischaemia — without changing heart rate or blood pressure.
Can Vastarel MR be used with other heart medications?
Yes, it is commonly used alongside other anti-anginal agents as an adjunct. Your cardiologist will advise on combinations.
Is it suitable for patients with movement disorders?
No. Trimetazidine is contraindicated in Parkinson's disease and parkinsonian symptoms.
Is a prescription required?
Yes. Vastarel MR is a prescription cardiovascular medicine.



